Venture Partners Xii News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Venture partners xii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Venture Partners Xii Today - Breaking & Trending Today

Arch Venture Partners Xii, Llc Buys 3,357 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc bought 3,357 shares of Neumora Therapeutics stock in a transaction on Tuesday, November 14th. The stock was acquired at an average price of $11.98 per share, for a total transaction of $40,216.86. Following the transaction, the insider now directly owns […] ....

United States , Stifel Nicolaus , William Blair , Neumora Therapeutics Inc , Group Plc , Securities Exchange Commission , Jpmorgan Chase Co , Royal Bank , Arch Venture Partners Xii Llc , Citigroup Inc , Neumora Therapeutics Company Profile , Qube Research Technologies Ltd , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Technologies Ltd , General Group Plc , Laurion Capital Management , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Purchases 30,192 Shares of Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 30,192 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was acquired at an average price of $11.50 per share, for a total transaction of $347,208.00. Following the acquisition, the insider now […] ....

United States , William Blair , Royal Bank , Jpmorgan Chase Co , Neumora Therapeutics Inc , Citigroup Inc , Arch Venture Partners Xii Llc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Venture Partners Xii , Therapeutics Stock Down , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Acquires 24,504 Shares of Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 24,504 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was acquired at an average price of $12.31 per share, for a total transaction of $301,644.24. Following the completion of the purchase, the insider […] ....

Arch Venture Partners Xii Llc , Securities Exchange Commission , Neumora Therapeutics Company Profile , Neumora Therapeutics Inc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Buys $681,502.80 in Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 60,740 shares of the company’s stock in a transaction that occurred on Monday, September 25th. The shares were purchased at an average cost of $11.22 per share, for a total transaction of $681,502.80. Following the completion of the transaction, […] ....

Neumora Therapeutics Company Profile , Neumora Therapeutics Inc , Securities Exchange Commission , Arch Venture Partners Xii Llc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Arch Venture Partners Xii, Llc Acquires 40,000 Shares

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc acquired 40,000 shares of the company’s stock in a transaction dated Friday, September 22nd. The shares were purchased at an average cost of $11.14 per share, for a total transaction of $445,600.00. Following the purchase, the insider now directly owns […] ....

Neumora Therapeutics Company Profile , Securities Exchange Commission , Neumora Therapeutics Inc , Arch Venture Partners Xii Llc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Exchange Commission , Venture Partners Xii , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,